BioTime Reports Isolation Of Novel Brain-Associated Cells From Human Embryonic Stem Cells

ALAMEDA, Calif.--(BUSINESS WIRE)--BioTime, Inc. (NYSE MKT: BTX), a biotechnology company that develops and markets products in the field of regenerative medicine reported today the publication of a peer-reviewed scientific paper on the successful generation of human cells with markers of particular cell types in the human brain, potentially useful in the treatment of neurological diseases such as Alzheimer’s disease. The paper published online (ahead of print) in the journal Regenerative Medicine, characterizes the cells generated from human embryonic stem cells using BioTime’s proprietary PureStem™ technology. The study reports that the new cell lines show the potential to become cartilage and bone as well as brain-associated cells such as membranes surrounding the brain called meninges and choroid plexus (the structure in the brain that creates cerebrospinal fluid). These novel expandable and highly purified progenitors have properties that may have a wide array of future applications in the practice of orthopedics and neurology.

Help employers find you! Check out all the jobs and post your resume.